Central Drugs Standard Control Organization (CDSCO): News
28 Jun 2023Uzbekistan
The India-made cough syrups linked to at least 19 deaths in Uzbekistan contained a toxic industrial-grade ingredient rather than the legitimate pharmaceutical version, Reuters reported.
18 Jan 2023Union Health Ministry
The Union Health Ministry on Tuesday rejected reports claiming that the Central Drugs Standard Control Organization (CDSCO) and Indian Council of Medical Research (ICMR) had admitted to numerous side effects of COVID-19 vaccines.
23 Dec 2022Vaccine
Union Health Minister Mansukh Mandaviya informed on Friday that the Centre has approved Bharat Biotech's nasal vaccine to be used as a heterologous booster.
12 Oct 2022World Health Organization
The Haryana government suspended cough syrup production at a Maiden Pharmaceuticals facility on Wednesday, a week after the World Health Organization (WHO) warned that the drug may be related to the deaths of scores of children in the Gambia.
06 Oct 2022Gambia
After the death of 66 children in the Gambia, the World Health Organization (WHO) issued an alert against using four fever, cold, and cough syrups manufactured by Maiden Pharmaceuticals Limited — an Indian pharmaceuticals company based in Haryana.
20 Aug 2021Drugs Controller General of India
The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) has recommended granting an emergency use authorization (EUA) to ZyCoV-D, the three-dose COVID-19 vaccine developed by Zydus Cadila, on Friday.
02 Aug 2021Johnson & Johnson
Johnson & Johnson has withdrawn its proposal seeking an accelerated approval of its COVID-19 vaccine, Janssen, in India, the country's drug regulator said.
30 Jul 2021Christian Medical College
The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organization (CDSCO) has given its go-ahead for conducting clinical trials involving the mixing and matching of Covishield and COVAXIN vaccine doses.
01 Jul 2021Drugs Controller General of India
A Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organization (CDSCO) has denied permission to Pune-based Serum Institute of India (SII) for conducting clinical trials of its second COVID-19 vaccine, Covovax, in children.
12 May 2021Vaccine
In a bid to extend the country's vaccination drive to include people below 18 years, an expert panel on Tuesday recommended Hyderabad-based Bharat Biotech's COVID-19 vaccine COVAXIN for phase 2/3 clinical trials on children and adolescents aged two to 18 years.
15 Apr 2021Coronavirus
India's drug regulator will make a decision on applications seeking approval for restricted emergency use of foreign-produced vaccines within three working days from the date of submission, the government said on Thursday.
20 Jan 2021Drugs Controller General of India
An expert panel, Central Drugs Standard Control Organisation, (CDSCO) on Tuesday recommended granting permission for conducting the Phase I clinical trial of an intranasal vaccine against COVID-19 developed by Bharat Biotech, official sources said.
03 Jan 2021Union Health Ministry
A government-appointed panel on Saturday recommended emergency-use authorization (EUA) to the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech.
01 Jan 2021Oxford
In a development that will soothe the coronavirus-battered nation, the Central Drugs Standard Control Organization (CDSCO) panel on Friday gave approval to the vaccine developed by the University of Oxford and British-pharma giant AstraZeneca.
31 Dec 2020India
The United Kingdom on Wednesday approved the vaccine developed by Oxford University and the British-Swedish pharmaceutical company AstraZeneca, giving the vaccine an endorsement that will likely be considered by Indian drug regulators.
02 Dec 2020Coronavirus
With the coronavirus vaccine trials being conducted by Serum Institute of India (SII) being shrouded in controversy after a participant complained of an "adverse reaction," the Centre on Tuesday said there's no need to stop the process.
08 Oct 2020Russia News
India's drug regulator has refused to allow a large scale clinical trial of Russia's Sputnik V COVID-19 vaccine.
16 Sep 2020Russia News
In a major development, Hyderabad-based pharma company Dr. Reddy's Laboratories has partnered with the Russian Direct Investment Fund (RDIF) to source their Sputnik V COVID-19 vaccine for India.
12 Aug 2020India
On Tuesday, Russia announced what it claims is the first COVID-19 vaccine, developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Moscow.
02 Jun 2020United States of America
Remdesivir has been approved by India's top drug regulator for "restricted emergency use" on COVID-19-infected adults and children.
24 Mar 2020India
In a major development, Pune-based molecular diagnostics company Mylab Discovery Solutions has been given the go-ahead to develop testing kits for the novel coronavirus disease (COVID-19).
06 Oct 2018Supreme Court Of India
The Supreme Court yesterday sought the Center's response on a plea alleging that "faulty" and "deadly" hip implants, made by US-based pharma major Johnson & Johnson (J&J), have been fitted into the bodies of 14,525 Indian patients, termed as "medical negligence" by an expert committee.
07 Sep 2018India
The Union Health Ministry has invited suggestions for renaming the country's drug regulator CDSCO in line with its expanded roles.
03 Jun 2018India
To ensure the quality of drugs, Health Ministry is planning to make companies, which market and promote medicines, responsible for any violation of drug regulations like manufacturers.
08 Apr 2018Ministry of Health and Family Welfare
Health Ministry has banned over-the-counter (OTC) sale of 14 steroid-based creams and ointments by bringing them under the Schedule H of the Drugs and Cosmetics Rules, 1945.
19 Sep 2017Climate Change
Bengaluru's Bellandur Lake frothing has turned the Centre's attention to high phosphorus content in laundry detergents, bars, and industrial cleaners.